Specific targeting of whole lymphoma cells to dendritic cells <it>ex vivo </it>provides a potent antitumor vaccine

Specific targeting of whole lymphoma cells to dendritic cells <it>ex vivo </it>provides a potent antitumor vaccine

<p>Abstract</p> <p>Background</p> <p>Dendritic cells (DC) pulsed with tumor-derived antigenic material have widely been used in antitumor vaccination protocols. However, the optimal strategy of DC loading has not yet been established. Our aim was to define requirements...

Full description

Bibliographic Details
Main Authors:	Mocikat Ralph, Mysliwietz Josef, Adam Christian
Format:	Article
Language:	English
Published:	BMC 2007-03-01
Series:	Journal of Translational Medicine
Online Access:	http://www.translational-medicine.com/content/5/1/16

Similar Items

Dendritic Cells in Anticancer Vaccination: Rationale for Ex Vivo Loading or In Vivo Targeting
by: Alexey V. Baldin, et al.
Published: (2020-03-01)

Dendritic cells combined with tumor cells and α-galactosylceramide induce a potent, therapeutic and NK-cell dependent antitumor immunity in B cell lymphoma
by: Laura Escribà-Garcia, et al.
Published: (2017-05-01)

Therapeutic Cancer Vaccination with Ex Vivo RNA-Transfected Dendritic Cells—An Update
by: Jan Dörrie, et al.
Published: (2020-01-01)

Dendritic Cells The Tumor Microenvironment and the Challenges for an Effective Antitumor Vaccination
by: Fabian Benencia, et al.
Published: (2012-01-01)

Enhancement of Antitumor Vaccination by Targeting Dendritic Cell-Related IL-10
by: Diana Llopiz, et al.
Published: (2018-09-01)

Shaping of Natural Killer Cell Antitumor Activity by Ex Vivo Cultivation
by: Markus Granzin, et al.
Published: (2017-04-01)

In Vivo Antitumor Effect against Murine Cells of CT26 Colon Cancer and EL4 Lymphoma by Autologous Whole Tumor Dead Cells
by: Carlos Barrera-Avalos, et al.
Published: (2021-01-01)

Exposure to Low-Dose Radiation Enhanced the Antitumor Effect of a Dendritic Cell Vaccine
by: Sinian Wang, et al.
Published: (2019-02-01)

Vaccination of Diffuse Large B- Cell Lymphoma Patients with Antigen-Primed Dendritic Cells
by: Saeid Abediankenari, et al.
Published: (2013-05-01)

Vaccination of Diffuse Large B- Cell Lymphoma Patients with Antigen-Primed Dendritic Cells
by: Masoud Bahrami, et al.
Published: (2013-05-01)

Hematopoietic stem cell-derived myeloid and plasmacytoid DC-based vaccines are highly potent inducers of tumor-reactive T cell and NK cell responses ex vivo
by: Soley Thordardottir, et al.
Published: (2017-03-01)

Antitumor Activity of Ethanolic Extract of Dendrobium formosum in T-Cell Lymphoma: An In Vitro and In Vivo Study
by: Ritika Prasad, et al.
Published: (2014-01-01)

Immune checkpoint blockade impairs immunosuppressive mechanisms of regulatory T cells in B-cell lymphoma
by: Vera Bauer, et al.
Published: (2021-09-01)

Overproduction of IFNg by Cbl-b-Deficient CD8+ T Cells Provides Resistance against Regulatory T Cells and Induces Potent Antitumor Immunity
by: Chung, D.C, et al.
Published: (2022)

Innate responses induced by whole inactivated virus or subunit influenza vaccines in cultured dendritic cells correlate with immune responses in vivo.
by: Maaike Stoel, et al.
Published: (2015-01-01)

Enhancing Dendritic Cell Migration to Drive Antitumor Responses
by: Batich, Kristen Anne
Published: (2017)

Effect of macrophage-activating factor (GcMAF-RF) upon ex vivo polarization of macrophages, activation of dendritic cells and production of cytokines by human whole blood cells
by: S. S. Kirikovich, et al.
Published: (2021-05-01)

Ex vivo expansion of human hematopoietic stem cells by garcinol, a potent inhibitor of histone acetyltransferase.
by: Taito Nishino, et al.
Published: (2011-01-01)

Ex Vivo Nicotine Stimulation Augments the Efficacy of Human Peripheral Blood Mononuclear Cell-Derived Dendritic Cell Vaccination via Activating Akt-S6 Pathway
by: Yan Yan Wang, et al.
Published: (2015-01-01)

A liposome-based mycobacterial vaccine induces potent adult and neonatal multifunctional T cells through the exquisite targeting of dendritic cells.
by: Arun T Kamath, et al.
Published: (2009-01-01)

A modular self-adjuvanting cancer vaccine combined with an oncolytic vaccine induces potent antitumor immunity
by: Krishna Das, et al.
Published: (2021-08-01)

THE IMPAIRMENT OF ANTITUMOR CYTOTOXIC ACTIVITY OF DENDRITIC CELLS IN PATIENTS WITH MALIGNANT LYMPHOMA DUE TO THE ALTERED EXPRESSION OF TUMOR NECROSIS FACTOR ALPHA
by: T. V. Tyrinova, et al.
Published: (2016-02-01)

Enhancing Antitumor Immunity of FasL-Transfected Lewis Lung Carcinoma Is Used by Dendritic Cell-Based Vaccine
by: Yi-Lin Tsai, et al.
Published: (2004)

Ascorbic acid supports ex vivo generation of plasmacytoid dendritic cells from circulating hematopoietic stem cells
by: Anders Laustsen, et al.
Published: (2021-09-01)

In vitro and ex vivo evaluation of tumor-derived exosome-induced dendritic cell dysfunction in mouse
by: Wenfeng Zeng, et al.
Published: (2021-03-01)

Perspectives on reprogramming cancer-associated dendritic cells for antitumor therapies
by: Fabian eBenencia, et al.
Published: (2014-04-01)

Cancer vaccines : using lentiviral vectors to deliver antigens to dendritic cells in vivo
by: Rowe, Helen
Published: (2006)

Day-4 myeloid dendritic cells pulsed with whole tumor lysate are highly immunogenic and elicit potent anti-tumor responses.
by: Cheryl Lai-Lai Chiang, et al.
Published: (2011-01-01)

Antitumor effect of murine dendritic and tumor cells transduced with IL-2 gene Antitumor effect of murine dendritic and tumor cells transduced with IL-2 gene
by: Justyna Wojas-Turek, et al.
Published: (2012-10-01)

Flavonoids in Ageratum conyzoides L. Exert Potent Antitumor Effects on Human Cervical Adenocarcinoma HeLa Cells In Vitro and In Vivo
by: Zeyan Lin, et al.
Published: (2020-01-01)

Optimized dendritic cell vaccination induces potent CD8 T cell responses and anti-tumor effects in transgenic mouse melanoma models
by: Mareike Grees, et al.
Published: (2018-07-01)

Potent ex vivo armed T cells using recombinant bispecific antibodies for adoptive immunotherapy with reduced cytokine release
by: Lawrence G Lum, et al.
Published: (2021-05-01)

Emerging natural killer cell immunotherapies: Large-scale ex vivo production of highly potent anticancer effectors
by: Garnet Suck, et al.
Published: (2010-07-01)

Dendritic Cell-Targeted Vaccines
by: Lelia eDelamarre, et al.
Published: (2014-05-01)

Intratumoral Lentivector-Mediated TGF-β1 Gene Downregulation As a Potent Strategy for Enhancing the Antitumor Effect of Therapy Composed of Cyclophosphamide and Dendritic Cells
by: Joanna Rossowska, et al.
Published: (2017-06-01)

Potent antitumor effects of cell-penetrating peptides targeting STAT3 axis
by: Maryam Aftabizadeh, et al.
Published: (2021-01-01)

Potent Antitumor Activity Generated by a Novel Tumor Specific Cytotoxic T Cell.
by: Zheng Wang, et al.
Published: (2013-01-01)

Exploiting a new strategy to induce immunogenic cell death to improve dendritic cell-based vaccines for lymphoma immunotherapy
by: B. Montico, et al.
Published: (2017-11-01)

Enhanced antitumor efficacy through microwave ablation combined with a dendritic cell-derived exosome vaccine in hepatocellular carcinoma
by: Xinyu Zhong, et al.
Published: (2020-01-01)

Low Photosensitizer Dose and Early Radiotherapy Enhance Antitumor Immune Response of Photodynamic Therapy-Based Dendritic Cell Vaccination
by: Bastien Doix, et al.
Published: (2019-08-01)

Cannot write session to /tmp/vufind_sessions/sess_e0a8sms4o630avpfq8r764uo64